Candriam SCA’s Viridian Therapeutics VRDN Stock Holding History

Candriam SCA’s Portfolio VRDN Stock Details VRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$12.1M	Sell
2025 Q1	$11.9M	Buy
2024 Q4	$14M	Sell
2024 Q3	$17.1M	Hold
2024 Q2	$9.75M	Buy
2024 Q1	$4.9M	Buy